The Fatty Acid Oxidation Disorders Gene Panel by NGS evaluates a comprehensive group of genes responsible for fatty acid metabolism and energy production. Using an EDTA blood sample, this test identifies mutations that can lead to metabolic crises, muscle weakness, hypoglycemia, and organ dysfunction. Metropolis Healthcare employs advanced next-generation sequencing to ensure precise variant detection and clinically relevant insights. The results support early diagnosis, newborn and family screening, and tailored metabolic management.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0198
Frequently Asked Questions (FAQ's):
What does the Fatty Acid Oxidation Disorders Gene Panel include at Metropolis Healthcare?
It analyzes multiple genes involved in fatty acid breakdown and energy metabolism using high-accuracy next-generation sequencing.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from an EDTA blood sample and sequences the targeted genes using advanced NGS platforms.
Who should consider taking this test at Metropolis Healthcare?
Individuals with recurrent hypoglycemia, exercise intolerance, metabolic crises, or a family history of fatty acid oxidation disorders may benefit from this panel.
What sample is required for this test at Metropolis Healthcare?
A routine EDTA blood sample is sufficient for reliable genetic sequencing.
How long does Metropolis Healthcare take to provide results?
Turnaround time depends on sequencing and interpretation steps, with reports shared promptly after detailed evaluation.
Why choose Metropolis Healthcare for this genetic test?
Metropolis Healthcare offers comprehensive gene coverage, stringent quality control, and clinically meaningful reporting.
Does Metropolis Healthcare provide support after test results?
Yes, expert genetic insights accompany the report to help clinicians understand findings and plan appropriate metabolic management.
Is this test suitable for infants and children at Metropolis Healthcare?
Yes, the panel is suitable for newborns, children, and adults when fatty acid oxidation disorders are suspected.